跳至主要内容
临床试验/NCT00383032
NCT00383032已完成不适用

Randomized Controlled Trial of Mifepristone Versus Laminaria for Cervical Ripening In Midtrimester Induction

Dartmouth-Hitchcock Medical Center2 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2004年1月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
72
试验地点
2
主要终点
induction to delivery time

研究概览

简要总结

Data from other countries have suggested that oral mifepristone used as a cervical ripening agent may decrease induction to delivery time in midtrimester inductions. To our knowledge, there are no trials comparing mifepristone to laminaria in a standard clinical setting with standardized misoprostol induction protocol to examine the issue of induction to delivery time. We hypothesize that mifepristone will work at least as well as laminaria for midtrimester cervical ripening prior to induction of labor with misoprostol.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • pregnant women with fetal anomalies, aneuploidy, or demise at 15-22 weeks gestation
  • age greater than 16
  • able to speak English

排除标准

  • prior uterine scar or
  • allergy or history of bad reaction to any of the study drugs or
  • history of chronic adrenal failure or
  • porphyria or
  • concurrent long-term corticosteroid treatment

结局指标

主要结局

induction to delivery time

次要结局

  • pain
  • delivery within 24 hours
  • need for post-partum D&C
  • adverse events

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验